Unleash the power of ultrasound.

Learn more

CLINICAL EVIDENCE

Discover a sound approach to hypertension treatment.

Proven effective in 3/3 U.S. and Europe randomized controlled trials.

Lasting, powerful results.

Procedural protection and long-term safety.

See the data

1. Azizi et al. JAMA. 2023;329(8):651-661 2. Azizi et al. Lancet. 2018 Jun 9;391(10137):2335-2345. 3. Azizi et al. Lancet. 2021 Jun 26;397(10293):2476-2486. 4. Kirtane et al. JAMA Cardiol. 2023;8(5):464-473 5. Rader et al. EuroIntervention 2022;18:e677-e685

ABOUT RECOR

We’re
changing the
game in
chronic care
therapies.

At Recor, our purpose is clear: to help people realize a future not bound by chronic disease.

Actual patient not pictured

CAREERS

Make a difference
at Recor.

Join us

Privacy Statement | Terms & Conditions | Corporate Governance | Patents | Connect

The PARADISE™ system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted.

© 2024 Recor Medical Europe GmbH. All rights reserved. RECOR MEDICAL and PARADISE™ are registered trademarks of Recor Medical, Inc. in the United States and other countries. RADIANCE, the RADIANCE logo, RECOR, HYDROCOOLING, the GPS logo, and SONOWAVE 360 are also trademarks of Recor Medical, Inc.
The PARADISE™ System is covered by US Patent.

Recor Medical, headquartered in Palo Alto, California, USA, a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd. recormedical.eu is Recor Medical, Otsuka Medical Devices Europe GmbH website (the Site). We control and operate this Site from Europe. This Site is intended for use by European residents only and contains information regarding the Paradise™ System, which is approved for sale in the EU and bears a CE mark.

Recor Medical Europe GmbH
Europa-Allee 52 · 60327 Frankfurt · Germany
Amtsgericht Frankfurt am Main: HRB 123214
Chief Executive Officers: Lara Barghout, Michael Jones, Ronan O`Connor

A high standard for lowering blood pressure.